Financial Trade Freedom - Investing and Stock News
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
  • Investing
  • News
  • Editor’s Pick
  • Economy
  • Stock
No Result
View All Result
Financial Trade Freedom - Investing and Stock News
No Result
View All Result
Home Investing

Here’s why the American Eagle stock price is flying today

admin by admin
December 3, 2025
in Investing
0
Here’s why the American Eagle stock price is flying today
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

American Eagle stock price continued its strong bull run in the extended hours after the company published strong results and boosted its guidance. AEO shares ended the session at $20.8 and then rose to $22.8 in the after-hours. So, will this surge continue?

American Eagle boosted by key marketing campaigns

AEO, the parent company of American Eagle, Aerie, and Offline, reported strong financial results, helped by its viral marketing campaigns with Travis Kelce, Sydney Sweeney, and Martha Stewart.

While some of these campaigns were controversial, they led to more website and store traffic, which translated into sales. The Chief Financial Officer said:

“The traffic we’re seeing digitally off of those campaigns is significant. That’s where we’re seeing a lot of the gains from those efforts and from the effectiveness of those campaigns.”

The financial results showed that its revenue rose to $1.36 billion from $1.28 billion in the same period last year. Its nine-month revenue rose to $3.735 billion from $3.724 billion in 2024. 

Eric Balchunas
@EricBalchunas
·Follow

American Eagle jumped 10% in after mkt trading following sales beat. The stock is now up 120% in past 5 months, which is 15x the S&P 500, since Sydney Sweeney blessed the brand. What a country. $AEO

1:47 AM · Dec 3, 2025
1
Reply
Read more on Twitter

The growth was driven by its American Eagle and Aerie businesses. American Eagle’s revenue rose to $853 million, while Aerie generated $461 million. Its other segment deteriorated, with its revenue dropping to $54 million. 

American Eagle’s performance is a sign that the company’s business continues to thrive despite the ongoing challenging market. As a big importer, the company is now paying more money in tariffs thanks to Donald Trump’s actions. It expects that the net impact of tariffs will be $70 million this year. 

It is also doing well as consumer inflation remained at an elevated level. The most recent results showed that the headline Consumer Price Index rose to 3%, while consumer confidence has retreated.

Its performance is a sign that middle and higher-earners are continuing to spend as wages have risen. Portfolios have also done well in the past few months, now that the stock market is in a bull market. 

American Eagle boosted its forward guidance as demand remained elevated. It now expects that the comparable store sales will be between 8% and 9% in Q4 and that its operating income will be between $155 million and $160 million. 

AEO’s performance mirrored that of Abercrombie & Fitch (ANF), whose stock soared by over 50% after its recent earnings. The Gap stock has jumped by 60% from its lowest level this year, while Urban Outfitters soared to $80 from last month’s low of $60.

AEO stock price technical analysis

American Eagle stock chart | Source: TradingView

The daily chart shows that the AEO stock price has rebounded in the past few months. It soared from the year-to-date low of $9.2 to $22 today. 

American Eagle has crossed the important resistance level at $20.30, the highest point on September 17. Moving above that level was important as the company invalidated the forming double-top pattern. 

It has moved to the 78.60% Fibonacci Retracement level and the Supertrend indicator. Therefore, the most likely AEO share price forecast is bullish, with the next point to watch being at $25, which is about 20% above the current level.

The post Here’s why the American Eagle stock price is flying today appeared first on Invezz


Previous Post

MIKE DAVIS: Why SCOTUS must reinstate Trump US Attorneys Alina Haba and Lindsey Halligan

Next Post

USD/TRY: Lira on edge as Turkish inflation dips, raising CBRT rate cut odds

Next Post
USD/TRY: Lira on edge as Turkish inflation dips, raising CBRT rate cut odds

USD/TRY: Lira on edge as Turkish inflation dips, raising CBRT rate cut odds

  • Trending
  • Comments
  • Latest
U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

U.S. homebuilders raise alarm over tariffs as sentiment falls to 5-month low

February 19, 2025
KFC moves U.S. headquarters from Kentucky to Texas

KFC moves U.S. headquarters from Kentucky to Texas

February 19, 2025
How Companies Use Derivatives To Hedge Risk

How Companies Use Derivatives To Hedge Risk

February 19, 2025
How crazy popcorn buckets became big business for movie theaters

How crazy popcorn buckets became big business for movie theaters

February 19, 2025
Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

0
Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

Tesla’s law firm drafts Delaware bill that could salvage Musk pay package

0
Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

0
How crazy popcorn buckets became big business for movie theaters

How crazy popcorn buckets became big business for movie theaters

0
Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

December 24, 2025
GLP-1 weight-loss pills set to reshape US food demand in 2026

GLP-1 weight-loss pills set to reshape US food demand in 2026

December 24, 2025
US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

December 24, 2025
Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

December 24, 2025

    Get Smarter with Your Money – Sign Up for Free Financial Tips!


    Join our community of savvy savers and investors! By signing up, you'll receive weekly emails packed with personalized financial tips, budgeting hacks, and investment strategies tailored to your income level. Take control of your finances today – it’s free and only takes a minute!

    Recent News

    Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

    Why US sanctioned former EU official, 4 others; what it says about transatlantic tech rift

    December 24, 2025
    GLP-1 weight-loss pills set to reshape US food demand in 2026

    GLP-1 weight-loss pills set to reshape US food demand in 2026

    December 24, 2025
    US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

    US stocks hold steady on Christmas Eve as investors watch Santa Claus rally

    December 24, 2025
    Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

    Agios Pharma jumps 15% as FDA expands use of anaemia drug mitapivat

    December 24, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved

    No Result
    View All Result
    • About us
    • Contacts
    • Email Whitelisting
    • Investing and Stock News
    • Privacy Policy
    • Terms and Conditions
    • Thank you

    Disclaimer: FinancialTradeFreedom.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 financialtradefreedom.com | All Rights Reserved